作者: Arne K. Andreassen , Kaspar Broch , Hans Eiskjær , Kristjan Karason , Einar Gude
DOI: 10.1097/TP.0000000000002445
关键词:
摘要: Background.Systemic hypertension is prevalent in heart transplant recipients and has been partially attributed to treatment with calcineurin inhibitors (CNIs). SCandinavian HEart De-novo stUdy earLy avoidancE trial was the first randomized study early